Lightning will never 'strike' an index fund like it did Biogen on Tuesday, Jim Cramer says

France Nouvelles Nouvelles

Lightning will never 'strike' an index fund like it did Biogen on Tuesday, Jim Cramer says
France Dernières Nouvelles,France Actualités
  • 📰 CNBC
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 72%

CNBC's Jim Cramer makes the case that investors should own individual stocks 'if you're willing to do the work' and 'try to beat the averages.'

CNBC's Jim Cramer makes the case for owning individual stocks alongside index funds "because lightning's never gonna strike that index fund of yours [the way] it struck Biogen" in Tuesday's session.

Cramer says he can't "blame anyone who lacks the time or the inclination to put in the homework" necessary to own individual stocks," but if you do, it's worth trying to beat the major averages.on Tuesday doubled down on his doctrine that investors should go beyond just owning index funds and also buy individual stocks.

"This could be a game changer for anyone with Alzheimer's. If this thing works, and the side effects are minimal, it could be easily ... the biggest drug in history, a blockbuster to end all blockbusters," Cramer said. "No wonder Biogen's stock caught fire."slid less than 11 points, or 0.36%. The largest single-day percentage gain that the large-cap index managed to post was nearly 5% last December, according to FactSet.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

CNBC /  🏆 12. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Biogen soars 40% on Alzheimer's drug revival: 'It would be the biggest drug ever,' Cramer saysBiogen soars 40% on Alzheimer's drug revival: 'It would be the biggest drug ever,' Cramer saysDrug maker Biogen announced it is seeking regulatory approval for its Alzheimer's drug, months after it stopped testing the treatment.
Lire la suite »

Jim Cramer warns that this bearish scenario in the S&P 500 is 'on the table'Jim Cramer warns that this bearish scenario in the S&P 500 is 'on the table'One trusted chart analyst thinks the market is still rallying but warns that investors should protect profits as 'real trouble' looms, says Jim Cramer on 'Mad Money.'
Lire la suite »

StockX's new CEO tells Jim Cramer going public is 'certainly our objective as a company'StockX's new CEO tells Jim Cramer going public is 'certainly our objective as a company''We're going after a global opportunity with consumers around the world and we're super excited about this innovation in commerce,' CEO Scott Cutler tells CNBC's Jim Cramer.
Lire la suite »

Apple is on fire and helping the chip stocks rally, Jim Cramer saysApple is on fire and helping the chip stocks rally, Jim Cramer says'We're getting some tremendous positive pin action here with some very important companies putting up excellent results and it's reverberating,' 'Mad Money's' Jim Cramer says.
Lire la suite »

Cramer says Biogen's Alzheimer's treatment could be 'the biggest drug ever' as shares soar 30%Cramer says Biogen's Alzheimer's treatment could be 'the biggest drug ever' as shares soar 30%Biogen is seeking FDA approval for its Alzheimer’s drug aducanumab. “It would be the biggest drug ever,” MadMoneyOnCNBC's JimCramer said.
Lire la suite »

Everything Jim Cramer said about the stock market on 'Mad Money,' including Apple's record highs, projecting the S&P 500, StockX CEO and cloud stocksEverything Jim Cramer said about the stock market on 'Mad Money,' including Apple's record highs, projecting the S&P 500, StockX CEO and cloud stocksCNBC's Jim Cramer breaks down how Apple and JPMorgan market action influence their respective sectors, forecasts what's ahead for the S&P 500 and sits down with new StockX CEO Scott Cutler.
Lire la suite »



Render Time: 2025-04-18 19:35:58